查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930072

全球灌注系統市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析及預測（2026-2034 年）

Perfusion Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 158 Pages | 商品交期: 請詢問到貨日

價格

灌注系統市場成長因子

由於慢性心血管和呼吸系統疾病的增加、器官移植手術的增多以及先進灌注技術的日益普及，全球灌注系統市場正經歷強勁增長。根據 Fortune Business Insights 預測，該市場規模預計將在 2025 年達到 54.5 億美元，從 2026 年的 59.7 億美元增長到 2034 年的 147.7 億美元，在預測期（2026-2034 年）內複合年增長率 (CAGR) 為 12.00%。

北美地區在 2025 年佔灌注系統市場的主導地位，市佔率為 39.50%。大量心肺手術、完善的醫療基礎設施以及主要市場參與者的存在都為此提供了支持。

市場驅動因素

體外循環系統是一種醫療設備，可在受控環境中模擬器官的自然功能，在心臟手術、器官移植和體外循環手術中發揮關鍵作用。由於心血管疾病、慢性肺病和腎衰竭等非傳染性疾病（NCDs）發病率的上升，全球體外循環手術的數量正在顯著增加。

此外，人口老化加劇也是市場成長的主要驅動因素。例如，到2023年，中國65歲及以上人口將達到2.034億，佔總人口的14.3%，這將直接增加對先進外科手術和體外循環支持系統的需求。

市場趨勢

機械灌注應用日益普及

影響市場的一個關鍵趨勢是，人們越來越傾向於選擇機械灌注，尤其是在器官保存方面。醫療機構和移植中心擴大採用低溫和常溫機械灌注技術，以提高器官存活率並降低移植後排斥反應率。

根據2023年移植受者科學登記數據，在DCD（臨終捐贈）中採用機械灌注的比例顯著提高，到2023年7月已達到約60%。這一趨勢正在加速離體器官灌注系統的研究和發展。

市場區隔分析

依產品類型

依產品類型劃分，市場可細分為心肺灌注系統、體外膜氧合（ECMO）及離體器官灌注系統。

  • 預計2026年，心肺灌注系統將佔市場主導地位，市佔率高達76.57%。這主要歸功於心臟和肺部手術以及移植手術數量的激增。
  • 由於全球ECMO中心數量的不斷增加，ECMO市場預計將穩定成長。
  • 由於研發投入的增加以及體外器官保存技術的應用，離體器官灌注系統預計將以最快的速度成長。

依年齡組別劃分

  • 預計到2026年，成人市場將佔58.42%的市場佔有率，主要受心血管疾病和器官衰竭高發生率的推動。
  • 由於先天性心臟病和兒童器官移植手術的增加，預計兒科市場將以顯著的複合年增長率增長。

依最終使用者劃分

  • 預計到2026年，醫院和門診手術中心（ASC）將佔市場主導地位，市場佔有率達45.60%，主要得益於其高手術量和先進的基礎設施。
  • 由於專業化程度的提高和臨床研究活動的開展，專科診所和研究機構預計將實現穩步增長。

區域概覽

  • 北美：受心臟手術量增加和產品創新強勁的推動，預計到 2025 年，市場規模將達到 21.6 億美元。美國市場預計到 2026 年將達到 22 億美元。
  • 歐洲：德國和法國移植手術量的增加以及器官捐贈系統的改進，推動了市場成長。
  • 亞太地區：由於人口老化和慢性病負擔加重，預計中國、日本和印度將實現最高的複合年增長率。
  • 拉丁美洲、中東和非洲：由於醫療基礎設施的改善和公眾意識提升活動的擴大，預計市場將實現溫和成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家主要心血管疾病盛行率（2025 年）
  • 主要國家主要器官移植數量（2025 年）
  • 主要產品及主要國家價格分析
  • 主要公司新產品發布
  • 關鍵產業趨勢：併購、業務夥伴關係
  • 新冠疫情對市場的影響

第五章 全球灌流系統市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 心肺灌注系統
      • 氧合系統
      • 體外循環機
      • 冷卻加熱設備
      • 血液參數監測系統
      • 離心式血液幫浦系統
      • 其他
    • 體外膜氧合（ECMO）
    • 離體器官灌注系統
  • 市場分析、洞察與預測：依年齡組別劃分
    • 成人
    • 兒童
  • 市場分析，洞察與預測：依最終用戶劃分
    • 醫院及門診手術中心
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美灌流系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲灌注系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 美國王國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太灌注系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲灌流系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東與非洲灌注系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC) 國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • Cardinal Health
    • Terumo Corporation
    • Medtronic
    • NIPRO
    • LivaNova PLC
    • Getinge
    • XVIVO
    • MicroPort Scientific Corporation
    • TransMedics
    • ECM Europe BV
Product Code: FBI103497

Growth Factors of perfusion systems Market

The global perfusion systems market is experiencing robust growth due to the increasing prevalence of chronic cardiovascular and respiratory diseases, rising organ transplantation procedures, and growing adoption of technologically advanced perfusion technologies. According to Fortune Business Insights, the market was valued at USD 5.45 billion in 2025 and is projected to grow from USD 5.97 billion in 2026 to USD 14.77 billion by 2034, registering a CAGR of 12.00% during the forecast period (2026-2034).

North America dominated the perfusion systems market in 2025, accounting for a 39.50% market share, supported by a high volume of cardiopulmonary procedures, strong healthcare infrastructure, and the presence of leading market players.

Market Drivers

Perfusion systems are medical devices that replicate the natural functioning of organs in a controlled environment and play a critical role during cardiac surgeries, organ transplantation, and extracorporeal circulation procedures. The rising incidence of non-communicable diseases (NCDs) such as cardiovascular disease, chronic lung disorders, and kidney failure is significantly increasing the number of cardiopulmonary bypass procedures globally.

Additionally, the growing geriatric population is a key contributor to market growth. For instance, China's population aged 65 years reached 203.4 million in 2023, accounting for 14.3% of the total population, which is directly increasing the demand for advanced surgical interventions and perfusion support systems.

Market Trends

Increasing Adoption of Machine Perfusion

A key trend shaping the market is the shifting preference toward machine perfusion, particularly for organ preservation. Healthcare organizations and transplant centers are increasingly adopting hypothermic and normothermic machine perfusion techniques to improve organ viability and reduce post-transplant rejection rates.

According to the 2023 Scientific Registry of Transplant Recipients, the adoption of machine perfusion for donation after circulatory death (DCD) organs increased significantly, reaching around 60% by July 2023. This trend is accelerating research activities and product development in isolated organ perfusion systems.

Market Segmentation Analysis

By Product Type

Based on product type, the market is segmented into cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), and isolated organ perfusion systems.

  • Cardiopulmonary perfusion systems dominated the market in 2026, holding a 76.57% share, driven by the high volume of heart and lung surgeries and transplant procedures.
  • The ECMO segment is expected to grow steadily due to the rising number of ECMO centers worldwide.
  • Isolated organ perfusion systems are projected to grow at the fastest rate, supported by increasing R&D efforts and adoption of ex-vivo organ preservation technologies.

By Age Group

  • The adult segment accounted for 58.42% market share in 2026, driven by a high prevalence of cardiovascular disorders and organ failures.
  • The pediatric segment is expected to grow at a significant CAGR due to increasing congenital heart disorders and pediatric transplant procedures.

By End User

  • Hospitals & ASCs dominated the market in 2026 with a 45.60% share, owing to higher procedure volumes and availability of advanced infrastructure.
  • Specialty clinics and research institutes are expected to witness steady growth due to rising specialization and increased clinical research activities.

Regional Insights

  • North America: Valued at USD 2.16 billion in 2025, driven by rising cardiac surgeries and strong product innovation. The U.S. market is projected to reach USD 2.20 billion by 2026.
  • Europe: Growth supported by increasing transplant procedures in Germany and France and improving organ donation frameworks.
  • Asia Pacific: Expected to register the highest CAGR, driven by a growing elderly population and rising chronic disease burden in China, Japan, and India.
  • Latin America & Middle East & Africa: Moderate growth due to improving healthcare infrastructure and rising awareness initiatives.

Competitive Landscape

The market is semi-consolidated, with major players such as LivaNova PLC, Getinge, Medtronic, XVIVO, and TransMedics holding a significant share. These companies are focusing on product launches, regulatory approvals, and R&D investments to strengthen their global presence.

Conclusion

The global perfusion systems market is poised for strong growth through 2034, driven by rising cardiopulmonary procedures, increasing organ transplantation, and technological advancements in machine perfusion systems. With the market expected to reach USD 14.77 billion by 2034, continuous innovation, expanding healthcare access, and growing awareness of advanced perfusion technologies will remain key growth enablers. Despite cost-related challenges in emerging economies, sustained investments by key players and supportive government initiatives are expected to strengthen market adoption worldwide.

Segmentation By Product Type

  • Cardiopulmonary Perfusion Systems
    • Oxygenation Systems
    • Heart-Lung Machines
    • Cooling and Heating Devices
    • Blood Parameter Monitoring Systems
    • Centrifugal Blood Pump Systems
    • Others
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Isolated Organ Perfusion Systems

By Age Group

  • Adults
  • Pediatrics

By End User

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, By Age Group, By End User, By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Cardiovascular Diseases - Key Countries, 2025
  • 4.2. Number of Major Organ Transplantations, By Key Countries, 2025
  • 4.3. Pricing Analysis, Key Products, Key Countries/Regions
  • 4.4. New Product Launches, Key Players
  • 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.6. Impact of COVID-19 on the Market

5. Global Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Cardiopulmonary Perfusion Systems
      • 5.1.1.1. Oxygenation Systems
      • 5.1.1.2. Heart-lung Machines
      • 5.1.1.3. Cooling and Heating Devices
      • 5.1.1.4. Blood Parameter Monitoring Systems
      • 5.1.1.5. Centrifugal Blood Pump Systems
      • 5.1.1.6. Others
    • 5.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 5.1.3. Isolated Organ Perfusion Systems
  • 5.2. Market Analysis, Insights and Forecast - By Age Group
    • 5.2.1. Adults
    • 5.2.2. Pediatrics
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Cardiopulmonary Perfusion Systems
      • 6.1.1.1. Oxygenation Systems
      • 6.1.1.2. Heart-lung Machines
      • 6.1.1.3. Cooling and Heating Devices
      • 6.1.1.4. Blood Parameter Monitoring Systems
      • 6.1.1.5. Centrifugal Blood Pump Systems
      • 6.1.1.6. Others
    • 6.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 6.1.3. Isolated Organ Perfusion Systems
  • 6.2. Market Analysis, Insights and Forecast - By Age Group
    • 6.2.1. Adults
    • 6.2.2. Pediatrics
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Cardiopulmonary Perfusion Systems
      • 7.1.1.1. Oxygenation Systems
      • 7.1.1.2. Heart-lung Machines
      • 7.1.1.3. Cooling and Heating Devices
      • 7.1.1.4. Blood Parameter Monitoring Systems
      • 7.1.1.5. Centrifugal Blood Pump Systems
      • 7.1.1.6. Others
    • 7.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 7.1.3. Isolated Organ Perfusion Systems
  • 7.2. Market Analysis, Insights and Forecast - By Age Group
    • 7.2.1. Adults
    • 7.2.2. Pediatrics
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Cardiopulmonary Perfusion Systems
      • 8.1.1.1. Oxygenation Systems
      • 8.1.1.2. Heart-lung Machines
      • 8.1.1.3. Cooling and Heating Devices
      • 8.1.1.4. Blood Parameter Monitoring Systems
      • 8.1.1.5. Centrifugal Blood Pump Systems
      • 8.1.1.6. Others
    • 8.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 8.1.3. Isolated Organ Perfusion Systems
  • 8.2. Market Analysis, Insights and Forecast - By Age Group
    • 8.2.1. Adults
    • 8.2.2. Pediatrics
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Cardiopulmonary Perfusion Systems
      • 9.1.1.1. Oxygenation Systems
      • 9.1.1.2. Heart-lung Machines
      • 9.1.1.3. Cooling and Heating Devices
      • 9.1.1.4. Blood Parameter Monitoring Systems
      • 9.1.1.5. Centrifugal Blood Pump Systems
      • 9.1.1.6. Others
    • 9.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 9.1.3. Isolated Organ Perfusion Systems
  • 9.2. Market Analysis, Insights and Forecast - By Age Group
    • 9.2.1. Adults
    • 9.2.2. Pediatrics
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Cardiopulmonary Perfusion Systems
      • 10.1.1.1. Oxygenation Systems
      • 10.1.1.2. Heart-lung Machines
      • 10.1.1.3. Cooling and Heating Devices
      • 10.1.1.4. Blood Parameter Monitoring Systems
      • 10.1.1.5. Centrifugal Blood Pump Systems
      • 10.1.1.6. Others
    • 10.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 10.1.3. Isolated Organ Perfusion Systems
  • 10.2. Market Analysis, Insights and Forecast - By Age Group
    • 10.2.1. Adults
    • 10.2.2. Pediatrics
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Cardinal Health
      • 11.2.1.1. Overview
      • 11.2.1.2. Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Terumo Corporation
      • 11.2.2.1. Overview
      • 11.2.2.2. Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. NIPRO
      • 11.2.4.1. Overview
      • 11.2.4.2. Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. LivaNova PLC
      • 11.2.5.1. Overview
      • 11.2.5.2. Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Getinge
      • 11.2.6.1. Overview
      • 11.2.6.2. Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. XVIVO
      • 11.2.7.1. Overview
      • 11.2.7.2. Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. MicroPort Scientific Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. TransMedics
      • 11.2.9.1. Overview
      • 11.2.9.2. Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. ECM Europe BV
      • 11.2.10.1. Overview
      • 11.2.10.2. Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 3: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 4: Global Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 7: North America Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 8: North America Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 9: North America Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Perfusion Systems Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 13: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 14: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 15: Europe Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 18: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 19: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 23: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 24: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type 2021-2034
  • Table 27: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 28: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 29: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Perfusion Systems Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Perfusion Systems Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Perfusion Systems Market Value Share (%), by Age Group, 2025 & 2034
  • Figure 4: Global Perfusion Systems Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Perfusion Systems Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 9: North America Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 10: North America Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 12: North America Perfusion Systems Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Perfusion Systems Market Value Share (%), By Country, 2025
  • Figure 14: Europe Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 17: Europe Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 18: Europe Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 25: Asia Pacific Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 26: Asia Pacific Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 33: Latin America Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 34: Latin America Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 41: Middle East & Africa Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 42: Middle East & Africa Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Perfusion Systems Market Share (%), By Company, 2025